Invited Speakers

Ke Cheng

Professor of Biomedical Engineering

Columbia University

Adjunct Professor

Dept. of Molecular Biomedical Sciences, NC State University

Dept. of Biomedical Engineering, UNC-Chapel Hill & NC State University

1060 William Moore Drive, BPC

Raleigh, North Carolina 27607, U.S.A.

Group Website: https://cheng-lab.net

Dr. Cheng is a Professor of Biomedical Engineering at Columbia University. He currently also serves as the Chair of the NIH Biomaterials and Biointerfaces (BMBI) study section. Previously, he was the Randall B. Terry, Jr. Distinguished Professor of Regenerative Medicine at NC State University and Professor in the UNC/NC State Joint Department of Biomedical Engineering. He also co-directed the NIH Comparative Molecular Medicine T32 Training Program and served as the Executive Director of Interdisciplinary Scholarship in NC State’s Office of the Provost.

Representative Publications

[1] Liu M., Hu S., Yan N., Popowski K.D., Cheng K. Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity. Nat Nanotech (2024) https://doi.org/10.1038/s41565-023-01580-3.

[2] Mei X., Li J., Wang Z., Zhu D., Huang K., Hu S., Popowski K.D., Cheng K. An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection. Nat Mater 22, 903-912 (2023).

[3]  Zhang K, Cheng K. Stem cell-derived exosome versus stem cell therapy. Nat Rev Bioeng 1, 608-609 (2023).

[4] Wang Z., Li Z., Shi W., Zhu D., Hu S., Dinh P.C., Cheng K. A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus. Sci Adv 9, eabo410 (2023).

[5] Wang Z, Popowski K.D., Zhu D., Abad B.L.J., Wang X., Liu M., Lutz H., Naeyer N.D., DeMarco C.T., Denny T.N., Dinh P.U.C., Li Z, Cheng K. Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nat Biomed Eng 6, 791-805 (2022)